Role of leukemia cell invadosome in extramedullary infiltration

Blood

Volumn 114, Issue 14, 2009, Pages 3008-3017

  Stefanidakis, Michael ^a,b   Karjalainen, Katja ^a,b   Jaalouk, Diana E ^b   Gahmberg, Carl G ^a   O'Brien, Susan ^b   Pasqualini, Renata ^b   Arap, Wadih ^b   Koivunen, Erkki ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEUKEMIC AGENT; ASPARTYLASPARTYLGLYCYLTRYPTOPHAN; BETA2 INTEGRIN; GELATINASE B; HISTIDYLPHENYLALANYLASPARTYLASPARTYLASPARTYLGLUTAMIC ACID; METALLOPROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CATALYSIS; CELL INFILTRATION; CELL INVASION; CELL MIGRATION; CELL SURFACE; COMPLEX FORMATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVE SITE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN MOTIF;

ANIMALS; ANTIGENS, CD18; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ENZYME PRECURSORS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOBLOTTING; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTES; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, NUDE; OLIGOPEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 70449494638     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-04-148643     Document Type: Article

References (28)

1. Scheinberg D, Maslak P, Weiss M. In: Vita V, Hellman S, Rosenberg S, eds. Cancer: Principles and Practice of Oncology. Philadelphia, PA: Lippincott-Raven; 2005:2404-2432.
2. Jandl JH, ed. Blood: Textbook of Haematology. 2nd ed. Toronto: Little, Brown and Co; 1996:1-1200.
3. Stefanidakis M, Koivunen E. Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression. Blood. 2006; 108(5):1441-1450. (Pubitemid 44316107)
4. 2 integrin by a small-molecule inhibits leukocyte migration and recruitment. Biochemistry. 2006;45(9):2862-2871.
5. 2 integrin modulator exerts antitumor activity in vivo. Anticancer Res. 2007;27(6B):3775-3782.
6. Wang C, Curtis JE, Minden MD, McCulloch EA. Expression of a retinoic acid receptor gene in myeloid leukemia cells. Leukemia. 1989;3(4):264-269. (Pubitemid 19092758)
7. Tsuchiya S, Kobayashi Y, Goto Y, et al. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 1982; 42(4):1530-1536.
8. Lin LI, Lin DT, Chang CJ, Lee CY, Tang JL, Tien HF. Marrow matrix metalloproteinases (MMPs) and tissue inhibitors of MMP in acute leukemia: potential role of MMP-9 as a surrogate marker to monitor leukaemic status in patients with acute myelogenous leukemia. Br J Haematol. 2002; 117(4):835-841.
9. Travaglino E, Benatti C, Malcovati L, et al. Biological and clinical relevance of matrix metallorproteinases 2 and 9 in acute myeloid leukemias and myelodysplastic syndromes. Eur J Hematol. 2008;80(3):216-226. (Pubitemid 351253461)
10. Nieborowska-Skorska M, Hoser G, Rink L, et al. Id1 Transcription inhibitor-matrix metalloproteinase 9 axis enhances invasiveness of the breakpoint cluster region/abelson tyrosine kinase- transformed leukemia cells. Cancer Res. 2006; 66(8):4108-4116.
11. Stefanidakis M, Björklund M, Ihanus E, Gahmberg CG, Koivunen E. Identification of a negatively charged peptide motif within the catalytic domain of progelatinases that mediates binding to leukocyte β2 integrins. J Biol Chem. 2003; 278(36):34674-34684. (Pubitemid 37553317)
12. Stefanidakis M, Ruohtula T, Borregaard N, Gahmberg CG, Koivunen E. Intracellular and cell surface localization of a complex between alpha(M)beta(2) integrin and promatrix metalloproteinase-9 progelatinase in neutrophils. J Immunol. 2004;172(11):7060-7068. (Pubitemid 38669148)
13. Bjorklund M, Heikkila P, Koivunen E. Peptide inhibition of catalytic and noncatalytic activities of matrix metalloproteinase-9 blocks tumor cell migration and invasion. J Biol Chem. 2004;279(28): 29589-29597. (Pubitemid 38915841)
14. Bjorklund M, Koivunen E. Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta. 2005;1755(1):37-69.
15. Gupton SL, Gertler FB. Filopodia: the fingers that do the walking [review]. Sci STKE. 2007;2007(400):re5.
16. Li R, Xie J, Kantor C, et al. A peptide derived from the intercellular-adhesion molecule-2 regulates the avidity of the leukocyte integrins CD11B/ CD18. J Cell Biol. 1995;129(4):1143-1153.
17. Koivunen E, Arap W, Valtanen H, et al. Tumor targeting with a selective gelatinase inhibitor. Nat Biotechnol. 1999;17(8):768-774. (Pubitemid 29365104)
18. Tian L, Yoshihara Y, Mizuno T, Mori K, Gahmberg CG. The neuronal glycoprotein telencephalin is a cellular ligand for the CD11a/CD18 leukocyte integrin. J Immunol. 1997;158(2):928-936. (Pubitemid 127492673)
19. Kjeldsen L, Bjerrum OW, Askaa J, Borregaard N. Subcellular localization and release of human neutrophil gelatinase, confirming the existence of separate gelatinase-containing granules. Biochem J. 1992;287(Pt2):603-610.
20. Giordano RJ, Cardo-Vila M, Lahdenranta J, Pasqualini R, Arap W. Biopanning and rapid analysis of selective interactive ligands. Nat Med. 2001;7(11):1249-1253. (Pubitemid 33063782)
21. Yakubenko VP, Lishko VK, Lam SCT, Ugarova TP. A molecular basis for integrin alphaMbeta2 ligand binding promiscuity. J Biol Chem. 2002; 277(50):48635-48642.
22. Redondo-Munoz J, Ugarte-Berzal E, Garcia-Marco JA, et al. {alpha}4{beta}1 integrin and 190 kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells. Blood. 2008;112(1):169-178.
23. Monferran S, Paupert J, Dauvillier S, Salles B, Muller C. The membrane form of the DNA repair protein Ku interacts at the cell surface with metalloproteinase 9. EMBO J. 2004;23(19):3758-3768. (Pubitemid 39389707)
24. 2 integrin subunit (DC18) from macrophages. Mol Cell Prot. 2009;8(5):1044-1060.
25. Matsunaga T, Takemoto N, Sato T, et al. Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor minimal residual disease of acute myelogenous leukemia. Nat Med. 2003;9(9):1158-1165. (Pubitemid 37173700)
26. Becker PS, Kopecky KJ, Wilks AN, et al. Very late antigen-4 of myeloblast correlates with improved overall survival for patients with acute myeloid leukemia. Blood. 2009;113(4):866-874.
27. De Toni F, Racaud-Sultan C, Chicanne G, et al. A crosstalk between the Wnt and the adhesiondependent signalling pathways govern the chemosensitivity of acute myeloid leukemia. Oncogene. 2006;25(22):3113-3122. (Pubitemid 43881553)
28. Ahn G-O, Brown M. Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: Role of bone marrow-derived myelomonocytic cells. Cancer Cell. 2008;13(3):193-205.